{"gene":"NRTN","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2019,"finding":"Cryo-EM structure of the NRTN/GFRα2/RET extracellular ternary complex revealed that NRTN and GFRα2 induce a specific dimerization mode of RET that brings two kinase domains into proximity for cross-phosphorylation. The NRTN/GFRα2/RET dimeric complex further packs into a tetrameric assembly, and cell-based assays showed this tetramer regulates RET endocytosis.","method":"Cryo-EM structure determination; cell-based endocytosis assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure with functional validation by cell-based assay; multiple orthogonal methods in a single rigorous study","pmids":["31535977"],"is_preprint":false},{"year":2019,"finding":"Cryo-EM structure of the complete extracellular RET signaling complex with NRTN and GFRα2 (5.7 Å) identified two key interaction points: (i) the calcium-binding site in RET contacts GFRα2 domain 3, and (ii) the RET cysteine-rich domain directly interacts with NRTN. This structure provides a model for how ternary complex formation leads to RET dimerization and activation.","method":"Cryo-EM structure determination (reconstituted full extracellular complex)","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution of complete extracellular complex and cryo-EM structure; independently consistent with parallel eLife 2019 study","pmids":["31392261"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of NRTN alone and in complex with GFRα2 (first structure of a GFRα with all three domains) showed that GFRα2 domain 1 does not interact directly with NRTN but may support interaction with RET/NCAM via a conserved surface. A heparan sulfate-binding site was identified on NRTN, and biophysical data showed relative GFRα2 concentration on cell surfaces affects NRTN functional affinity through avidity. A NRTN mutant with reduced heparan sulfate affinity showed increased in vivo exposure.","method":"X-ray crystallography; biophysical binding assays; mutagenesis; in vivo pharmacokinetic studies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with mutagenesis and biophysical assays, multiple orthogonal methods in one study","pmids":["29414779"],"is_preprint":false},{"year":1999,"finding":"After sciatic nerve injection, NRTN was retrogradely transported by two populations of dorsal root ganglion sensory neurons: a major population of small, RET+/IB4+/non-TrkA neurons that also transport GDNF, and a minor calretinin-expressing population that does not transport GDNF. Cross-competition studies showed only limited competition between NRTN and GDNF, indicating GFRα coreceptor-specific transport in vivo.","method":"In vivo retrograde transport assay; immunohistochemistry; competition experiments","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct in vivo retrograde transport experiments with competition controls; replicated across multiple neuronal populations","pmids":["10531437"],"is_preprint":false},{"year":2001,"finding":"GDNF and NRTN are target-derived factors for developing ciliary ganglion neurons. GDNF and NRTN are secreted from eye muscle (the target tissue) during the period of ciliary axon innervation. In vitro and in vivo function-blocking of GDNF at early embryonic ages suppressed ciliary axon outgrowth. After GDNF expression declines in the target, GFRα1 and RET (but not GFRα2) are downregulated in innervating neurons, suggesting target-derived GDNF regulates coreceptor expression.","method":"In vitro and in vivo function-blocking antibody assays; in situ hybridization; immunohistochemistry","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — both in vitro and in vivo function-blocking with consistent results; defined target-derived mechanism","pmids":["11585803"],"is_preprint":false},{"year":2013,"finding":"NRTN signals through GFRα2c and RET9 isoforms specifically to induce serine-727 (but not tyrosine-705) phosphorylation of STAT3 in neurons. A serine-dominant-negative STAT3 mutant impaired NRTN-induced neurite outgrowth, while a tyrosine-dominant-negative mutant did not. Mitochondrially localized P-Ser-STAT3 was identified as the downstream mediator of NRTN-induced neurite outgrowth (transcription-independent mechanism).","method":"Isoform-specific expression; dominant-negative mutagenesis; phospho-specific immunoblotting; subcellular fractionation; neurite outgrowth assays","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (mutagenesis, fractionation, functional assay) from a single lab","pmids":["23872421"],"is_preprint":false},{"year":2007,"finding":"In ciliary ganglion neurons, NRTN promotes survival exclusively via its cognate receptor GFRα2 (demonstrated by receptor-specific neutralizing antibodies), and unlike GDNF, NRTN-mediated survival and signaling does not require TGFβ. TGFβ does not promote recruitment of GFRα2 to the plasma membrane (in contrast to GFRα1), and disruption of TGFβ signaling does not impair NRTN-mediated survival.","method":"Receptor-specific neutralizing antibody assays; radioligand binding; immunocytochemistry; neuronal survival assays","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (binding, survival, antibody blocking) from a single lab; distinct mechanistic contrast with GDNF established","pmids":["17953664"],"is_preprint":false},{"year":2003,"finding":"NRTN-deficient (NRTN−/−) mice show reduced aqueous tear production, corneal sensation, mucin expression, and goblet cell density, with increased ocular surface inflammation (elevated IL-1β, TNF-α, MMP-9), demonstrating NRTN is required for parasympathetic innervation of the lacrimal gland and maintenance of ocular surface homeostasis.","method":"Knockout mouse phenotyping; tear function assays; immunofluorescence; ELISA; zymography; RT-PCR","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with multiple orthogonal functional readouts; well-controlled study","pmids":["14507865"],"is_preprint":false},{"year":2009,"finding":"NRTN knockout mice contain only 35% the normal number of cardiac cholinergic neurons (15% smaller), with 87% reduction in cholinergic nerve density at the sinoatrial node, substantially lower atrial acetylcholine, and reduced vagal bradycardia. Post-junctional sensitivity to muscarinic agonists was normal, placing NRTN's role specifically in maintaining presynaptic cholinergic innervation and cholinergic control of heart rate.","method":"Nrtn knockout mouse; immunohistochemistry; confocal microscopy; quantitative image analysis; ACh measurement; vagal nerve stimulation; isolated atria pharmacology","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with multiple orthogonal functional and structural readouts; clear mechanistic placement","pmids":["19176599"],"is_preprint":false},{"year":2008,"finding":"NRTN deficiency (knockout mice) led to diminished scotopic and photopic electroretinogram responses, thinning of the outer plexiform layer, reduction in horizontal cell dendrites and axons, and mislocalized synaptic complexes. GFRα2 expression was restricted to a subset of amacrine and ganglion cells; photoreceptors and Müller cells did not express GFRα1, GFRα2, or RET, indicating NRTN/RET signaling acts on horizontal and amacrine cells rather than photoreceptors.","method":"Electroretinography; NRTN/RET knockout and conditional mice; fluorescence reporter expression mapping; morphologic analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple knockout models with electroretinography and detailed anatomical analyses; clear target cell identification","pmids":["18417692"],"is_preprint":false},{"year":2000,"finding":"NRTN mRNA is expressed in smooth muscle of penile blood vessels and corpus cavernosum; GFRα2 and RET mRNAs are expressed in virtually all major pelvic ganglion neurons. 125I-NRTN injected into the penis was retrogradely transported to major pelvic and dorsal root ganglia. GFRα2-deficient mice had significantly fewer NOS-containing nerve fibers in penile nerves, establishing NRTN as a target-derived trophic factor for penile erection-inducing parasympathetic neurons via GFRα2/RET.","method":"In situ hybridization; radioligand retrograde transport assay; GFRα2 knockout immunohistochemistry","journal":"Journal of neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — retrograde transport assay plus genetic knockout; single lab, two complementary methods","pmids":["10770848"],"is_preprint":false},{"year":2000,"finding":"GFRα2-deficient mice show normal early gangliogenesis in cranial parasympathetic ganglia but postnatal amplification of neuron loss and atrophy in submandibular and otic ganglia, accompanied by complete loss of target innervation. Sphenopalatine neurons were not reduced numerically despite complete loss of target innervation. This establishes that NRTN/GFRα2/RET signaling is essential for the development and maintenance of parasympathetic target innervation (distinct from GDNF/GFRα1/RET, which is required for early gangliogenesis).","method":"GFRα1, GFRα2, and RET knockout mouse histology; in situ hybridization; immunohistochemistry","journal":"The European journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis across multiple knockout lines with quantitative anatomical readouts; clear pathway placement","pmids":["11069590"],"is_preprint":false},{"year":2021,"finding":"Muscle-derived NRTN acts as a myokine that signals retrogradely to motor neurons to promote slow motor neuron identity (RNA sequencing of motor neuron somas from HSA-NRTN transgenic mice). In muscle, NRTN increased capillary density, oxidative capacity, and induced transcriptional reprogramming toward fatty acid metabolism. HSA-NRTN mice phenocopied muscle-specific PGC-1α1 overexpression.","method":"Muscle-specific NRTN transgenic mice; RNA sequencing of motor neuron somas; metabolic phenotyping; immunohistochemistry","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic gain-of-function model with RNA-seq and multiple physiological readouts; novel myokine mechanism established","pmids":["34592133"],"is_preprint":false},{"year":2021,"finding":"Calcium imaging combined with differential Gfra1 and Gfra2 expression analysis in enteric neurons showed that GDNF and NRTN acutely and differentially regulate activity of ~50% of myenteric neurons, with distinct effects on smooth muscle contractions.","method":"Single-nucleus/single-cell RNA-seq; calcium imaging; immunohistochemistry; conditional knockout mice","journal":"Cellular and molecular gastroenterology and hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — calcium imaging with RNA-seq validation; single study but two orthogonal methods","pmids":["33444816"],"is_preprint":false},{"year":2022,"finding":"Sympathetic cholinergic nerve fibers establish a neurotrophic dependency with bone-embedded osteocytes via NRTN/GFRα2. An IL-6-induced cholinergic switch in sympathetic fibers occurs postnatally upon bone contact, and osteocytes require cholinergic innervation for survival and connectivity. Loss of cholinergic skeletal innervation caused osteopenia and impaired skeletal adaptation to exercise, establishing a NRTN-dependent neuro-osteocyte interface.","method":"Conditional and global knockout mice; lineage tracing; immunohistochemistry; micro-CT; exercise models","journal":"Cell stem cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with multiple functional readouts; single lab","pmids":["35276096"],"is_preprint":false},{"year":2013,"finding":"In pancreatic cancer cells, NRTN promoted proliferation and invasion via GFRα2. siRNA silencing of NRTN limited PCC proliferation and invasion. Depletion of NRTN from cancer tissue extracts and PCC supernatants decreased axonal sprouting in neuronal cultures. Paradoxically, NRTN silencing in PCCs boosted neural invasion.","method":"siRNA knockdown; MTT viability assay; Matrigel invasion assay; in vitro neuroplasticity assay; 3D neural migration assay; immunohistochemistry; qRT-PCR; immunoblotting","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple in vitro functional assays with knockdown; single lab","pmids":["24067900"],"is_preprint":false},{"year":2012,"finding":"In chronic pancreatitis, NRTN/GFRα2 axis is activated (upregulated mature multimeric NRTN and elevated GFRα2). Depletion of NRTN from chronic pancreatitis tissue extracts using blocking antibodies reduced neurotrophic effects on DRG neurons in vitro (decreased axonal sprouting), while NRTN depletion did not affect glial cell density, establishing NRTN as a key mediator of reactive neural alterations in chronic pancreatitis.","method":"Immunohistochemistry; immunoblotting; qRT-PCR; in vitro neuroplasticity assay with NRTN depletion","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — depletion experiments in ex vivo assay combined with human tissue analysis; single lab","pmids":["22961804"],"is_preprint":false},{"year":2013,"finding":"NRTN overexpression in keratinocytes (NRTN-OE mice) increased density of PGP9.5-positive free nerve endings, hypertrophied GFRα2-immunopositive sensory neuron somas, increased mRNAs for GFRα2, RET, P2X3, ASIC2a, and TRPM8 in sensory ganglia, and elevated behavioral sensitivity to mechanical stimuli, cool temperature, and menthol. The increase in cool/menthol sensitivity correlated directly with elevated TRPM8 expression.","method":"Transgenic NRTN overexpression; immunohistochemistry; electron microscopy; RT-PCR; behavioral testing; calcium imaging","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic gain-of-function with multiple orthogonal molecular and behavioral readouts; well-controlled study","pmids":["23365243"],"is_preprint":false},{"year":2006,"finding":"In adult mouse heart, NRTN mRNA is expressed in atrial and ventricular tissue, and >90% of cardiac parasympathetic ganglion neurons express both RET and GFRα2 (the NRTN receptor complex). GFRα2 is present in most cholinergic nerve fibers and Schwann cells, with some cholinergic sinoatrial node fibers also expressing RET, suggesting ongoing neurotrophic support of adult cardiac cholinergic innervation by NRTN.","method":"RT-PCR; immunohistochemistry; confocal microscopy","journal":"Cell and tissue research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization study linking NRTN receptor expression to specific cardiac neural populations; multiple methods but no functional manipulation","pmids":["16708241"],"is_preprint":false},{"year":2007,"finding":"In chick embryo liver development, NRTN is expressed in endothelial cells of the ductus venosus while GFRα2 is expressed in the liver bud. Inhibition of GFRα2 signaling suppressed liver bud elongation along the ductus venosus without affecting cell proliferation or apoptosis. Ectopic NRTN expression perturbed directional migration. In vitro, liver buds selectively migrated toward NRTN-soaked beads, establishing NRTN as a chemoattractant for GFRα2-expressing liver bud cells.","method":"In situ hybridization; GFRα2 signaling inhibition in ovo; ectopic NRTN expression; in vitro bead chemotaxis assay","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — function-blocking and gain-of-function in vivo plus in vitro chemotaxis; single lab with two orthogonal approaches","pmids":["17509555"],"is_preprint":false},{"year":2000,"finding":"Seizure activity regulates GFRα2 gene expression in limbic structures, and mice lacking GFRα2 show markedly suppressed epileptogenesis in the hippocampal kindling model, with lower hyperexcitability at 6–8 weeks post-kindling. This places NRTN signaling through GFRα2 as a modulator of seizure susceptibility, potentially via hilar neuropeptide Y-containing interneurons and entorhinal cortical afferents.","method":"GFRα2 knockout mice; hippocampal kindling electrophysiology; in situ hybridization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with electrophysiological readout; single lab; pathway placement somewhat indirect","pmids":["11050250"],"is_preprint":false},{"year":2011,"finding":"After peripheral nerve injury, GFRα2-positive cutaneous sensory neurons (normally NRTN-responsive) switch phenotype: GFRα2 immunoreactivity is rapidly lost and neurons begin expressing GFRα3 and TRPV1. NRTN failed to prevent neuronal death or ATF3 upregulation in vitro, while NGF and ARTN succeeded, correlating with the loss of GFRα2. This switch was correlated with downregulation of the transcription factor Runx1.","method":"Retrograde labeling; nerve cut injury; in vitro survival/ATF3 assays with GFL treatment; immunohistochemistry; RT-PCR","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — injury model with in vitro functional validation and transcription factor correlation; single lab, multiple methods","pmids":["22216140"],"is_preprint":false},{"year":2020,"finding":"Human lung-resident macrophages express GFRα2 and RET; type I interferon upregulates RET on macrophages. Epithelial-derived NRTN binding to the GFRα2/RET complex on macrophages dampens pro-inflammatory cytokine release and modulates matrix metalloproteinase production in response to viral stimuli, establishing a non-neuronal immunomodulatory role for NRTN in lung macrophages.","method":"Human lung macrophage cultures; cytokine measurement (ELISA); type I IFN stimulation; receptor expression analysis","journal":"Life science alliance","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional ex vivo experiments in human cells with mechanistic receptor identification; single lab","pmids":["33020210"],"is_preprint":false},{"year":2023,"finding":"TANGO1 interacts with NRTN in hepatocellular carcinoma cells (validated by endogenous Co-IP and confocal colocalization), and both proteins promote HCC progression by activating the PI3K/AKT/mTOR signaling pathway.","method":"Endogenous Co-immunoprecipitation; confocal colocalization; RNA-seq; knockdown functional assays","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP and colocalization with pathway analysis; single lab, limited mechanistic depth on NRTN's specific role","pmids":["37211171"],"is_preprint":false},{"year":2018,"finding":"AML cells activate RET signaling via NRTN/GFRα2 ligand/co-receptor complexes. Downstream, RET activates mTORC1-mediated autophagy suppression, which stabilizes leukemogenic drivers such as mutant FLT3. Genetic or pharmacologic RET inhibition impaired AML growth and was accompanied by upregulation of autophagy and FLT3 depletion.","method":"Functional genomic screen; co-receptor expression analysis; RET inhibition (genetic and pharmacologic); autophagy and FLT3 assays; mouse AML models; primary patient samples","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple experimental models (cell lines, mouse, primary patient) with pathway validation; NRTN/GFRα2 identified as the activating ligand/co-receptor complex for RET in AML","pmids":["29654265"],"is_preprint":false},{"year":2008,"finding":"In chicken retinospheres (3D model), exogenous NRTN activated PI3K and MAPK signaling pathways, with MAPK activation localizing specifically to acetylcholinesterase-positive cells in the innermost rows of the inner nuclear layer. NRTN application increased the number of acetylcholinesterase-positive cells at late culture stages; Müller glia did not express GFRα2 and were not involved in NRTN signaling.","method":"3D retinosphere culture; exogenous NRTN treatment; signaling pathway analysis (phospho-specific antibodies); immunohistochemistry; cell counting","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assay with pathway activation and cell-type-specific analysis; single lab, in vitro model","pmids":["18673446"],"is_preprint":false},{"year":2016,"finding":"NRTN and GDNF were identified as proneurogenic ligands in the embryonic cortex: cortical neurons (but not neural precursor cells) secrete factors promoting NPC differentiation, and NRTN promotes neurogenic differentiation of NPCs in vivo.","method":"Transcriptome profiling; cell-surface mass spectrometry; computational modeling; in vivo neurogenesis assays","journal":"Neuron","confidence":"Low","confidence_rationale":"Tier 3 / Weak — in vivo functional validation mentioned but method detail is limited in abstract; single study","pmids":["27545711"],"is_preprint":false},{"year":2025,"finding":"Pathogenic LRRK2 mutations inhibit primary cilia formation in striatal cholinergic/parvalbumin interneurons and astrocytes, blocking Hedgehog signaling and reducing GDNF and NRTN production. MLi-2 LRRK2 inhibitor treatment restored primary cilia, Hedgehog-responsive Gdnf and Nrtn expression, and striatal dopaminergic process density.","method":"LRRK2 mutant mice; dietary MLi-2 treatment; immunofluorescence for cilia; gene expression analysis; dopaminergic axon density quantification","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological manipulation with multiple functional readouts; establishes NRTN production as downstream of Hedgehog/cilia signaling in striatum","pmids":["40591712"],"is_preprint":false},{"year":2025,"finding":"NRTN when injected intramuscularly alongside tetanus neurotoxin fragment (HcT) to track signaling endosome transport in motor neurons in vivo produced no detectable change in retrograde endosome transport dynamics in either fast or slow motor neurons (negative result), in contrast to CNTF which markedly slowed endosome transport.","method":"In vivo intramuscular injection; live imaging of sciatic nerve axonal transport in anaesthetised mice; fluorescent HcT endosome tracking","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — rigorous in vivo imaging assay; negative result for NRTN specifically; preprint, not yet peer-reviewed","pmids":[],"is_preprint":true},{"year":2017,"finding":"Subcutaneous NRTN administration to Zucker diabetic fatty rats prevented hyperglycemia, increased pancreatic insulin content and β-cell mass, and preserved islet organization. Acute NRTN treatment did not activate c-Fos in brain feeding centers or directly enhance glucose-stimulated insulin secretion from isolated β-cells, indicating the antidiabetic effect is not mediated through central appetite regulation or direct β-cell insulin secretion.","method":"In vivo subcutaneous administration in ZDF rats; c-Fos immunohistochemistry in brain; isolated β-cell glucose-stimulated insulin secretion assay; metabolic phenotyping","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo model with mechanistic exclusion experiments (central c-Fos, direct β-cell assay); single lab","pmids":["28408435"],"is_preprint":false},{"year":2025,"finding":"BHLHE40 binds to the NRTN promoter (confirmed by ChIP-qPCR and dual luciferase assay) and reduces NRTN transcriptional activity in macrophages. In OVA-challenged asthmatic mice, simultaneous knockdown of Bhlhe40 and Nrtn recovered alternative macrophage activation and rescued the asthma phenotype, placing NRTN as a downstream transcriptional target of BHLHE40 that promotes M2 macrophage activation.","method":"Dual luciferase promoter assay; ChIP-qPCR; siRNA knockdown in vivo and in vitro; OVA asthma mouse model; macrophage polarization assays","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter-binding evidence plus in vivo epistasis; single lab","pmids":["40467844"],"is_preprint":false},{"year":2022,"finding":"In colorectal cancer cells, NRTN promoted migration/invasion by upregulating ZEB1 and N-cadherin (EMT markers) and promoted angiogenesis by upregulating VEGF-A. NRTN inhibition prevented CRC metastasis and angiogenesis in vivo.","method":"siRNA/overexpression functional assays; migration/invasion assays; endothelial tube formation; in vivo xenograft/metastasis models; Western blotting","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo functional experiments with molecular mechanism identification; single lab","pmids":["35114191"],"is_preprint":false},{"year":2001,"finding":"Targeted overexpression of NRTN in mouse testis caused transient degeneration of spermatids and pachytene spermatocytes between 3–5 weeks of age (in ~20% of transgenic lines), with no defect after 5 weeks and normal fertility, suggesting NRTN may regulate survival/differentiation of spermatocytes and spermatids but is not essential for spermatogenesis.","method":"Testis-specific NRTN transgenic mice; histology; phenotypic analysis","journal":"Molecular and cellular endocrinology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single gain-of-function transgenic approach; low penetrance limits mechanistic conclusions","pmids":["11694339"],"is_preprint":false}],"current_model":"NRTN is a secreted homodimeric member of the GDNF family that signals canonically by first binding its GPI-anchored co-receptor GFRα2 (and less selectively GFRα1); the NRTN/GFRα2 complex then recruits and dimerizes the RET receptor tyrosine kinase (with a key RET cysteine-rich domain–NRTN contact and a calcium-binding–GFRα2 domain 3 contact), driving RET kinase cross-phosphorylation and downstream activation of PI3K, MAPK, and isoform-specific STAT3 (serine-727, mitochondria-localized) pathways; the NRTN/GFRα2/RET ternary complex can further assemble into a tetramer that regulates RET endocytosis, and heparan sulfate participates in assembly of the signaling complex. In the peripheral nervous system NRTN acts as a target-derived retrograde trophic factor—retrogradely transported in a GFRα coreceptor-specific manner—that is essential for postnatal survival and target innervation by parasympathetic (cranial, cardiac, lacrimal, penile), sensory, and enteric neurons, and for retinal function via horizontal and amacrine cells. Beyond neurons, muscle-secreted NRTN functions as a myokine that retrogradely promotes slow motor neuron identity while increasing muscle oxidative metabolism; in the immune compartment NRTN (downstream of IFN-induced RET/GFRα2 up-regulation) dampens viral pro-inflammatory responses in lung macrophages; and in bone, sympathetic cholinergic fibers maintain osteocyte survival via NRTN/GFRα2 signaling. NRTN production in the striatum is controlled by Hedgehog signaling in primary cilia of cholinergic and parvalbumin interneurons and astrocytes, linking pathogenic LRRK2 and GBA1 mutations to reduced NRTN output and dopaminergic neuron vulnerability in Parkinson's disease."},"narrative":{"mechanistic_narrative":"NRTN is a secreted GDNF-family neurotrophic factor that signals by binding the GPI-anchored co-receptor GFRα2, which then recruits and dimerizes the RET receptor tyrosine kinase to trigger downstream signaling [PMID:31535977, PMID:31392261, PMID:17953664]. Structural studies define the assembly: NRTN and GFRα2 impose a specific RET dimerization mode that juxtaposes two kinase domains for cross-phosphorylation, with the RET cysteine-rich domain contacting NRTN and the RET calcium-binding site contacting GFRα2 domain 3; the resulting dimeric complex further packs into a tetramer that regulates RET endocytosis, and a heparan sulfate-binding site on NRTN participates in complex assembly and modulates in vivo exposure [PMID:31535977, PMID:31392261, PMID:29414779]. Downstream of RET, NRTN activates PI3K and MAPK and, in an isoform-specific manner (GFRα2c/RET9), drives serine-727 phosphorylation of mitochondrially localized STAT3 to support neurite outgrowth through a transcription-independent route [PMID:23872421, PMID:18673446]. Physiologically, NRTN functions as a target-derived retrograde trophic factor transported in a GFRα coreceptor-specific manner and required for postnatal survival and target innervation of parasympathetic neurons—including lacrimal, cardiac, and penile populations—as well as sensory neurons and retinal horizontal/amacrine cells [PMID:10531437, PMID:14507865, PMID:19176599, PMID:18417692, PMID:10770848, PMID:11069590]. Beyond classical neurotrophism, NRTN acts as a muscle-secreted myokine that retrogradely promotes slow motor neuron identity while raising muscle oxidative metabolism [PMID:34592133], supports a sympathetic-cholinergic neuro-osteocyte survival interface in bone [PMID:35276096], and dampens pro-inflammatory cytokine release from interferon-primed lung macrophages [PMID:33020210]. Its striatal production is controlled by Hedgehog signaling in primary cilia, linking pathogenic LRRK2 mutations to reduced NRTN output and dopaminergic vulnerability [PMID:40591712]. NRTN/GFRα2/RET signaling is also co-opted by pancreatic, colorectal, hepatocellular, and acute myeloid leukemia cells to drive proliferation, invasion, and survival [PMID:24067900, PMID:37211171, PMID:29654265, PMID:35114191].","teleology":[{"year":1999,"claim":"Established that NRTN is a target-derived factor delivered by retrograde axonal transport and that its uptake is coreceptor-specific rather than shared with GDNF, defining how peripheral neurons distinguish GDNF-family ligands.","evidence":"In vivo sciatic nerve retrograde transport with cross-competition in dorsal root ganglion neuron populations","pmids":["10531437"],"confidence":"High","gaps":["Did not resolve the molecular transport machinery","Receptor isoform usage not dissected at structural level"]},{"year":2000,"claim":"Genetic loss of GFRα2 separated NRTN's role from GDNF's: NRTN/GFRα2/RET is dispensable for early gangliogenesis but essential for postnatal parasympathetic survival and target innervation.","evidence":"GFRα1, GFRα2, and RET knockout mouse histology and innervation analysis; penile retrograde transport plus GFRα2-knockout phenotyping","pmids":["11069590","10770848"],"confidence":"High","gaps":["Downstream signaling events not assayed","Mechanism of selective postnatal dependence unresolved"]},{"year":2003,"claim":"Defined a concrete physiological output of NRTN signaling—parasympathetic innervation of the lacrimal gland and ocular surface homeostasis—through systematic knockout phenotyping.","evidence":"NRTN knockout mouse tear function, ocular surface inflammation, and innervation readouts","pmids":["14507865"],"confidence":"High","gaps":["Cell-autonomous vs systemic effects not separated","Signaling pathway within neurons not addressed"]},{"year":2007,"claim":"Showed NRTN promotes ciliary neuron survival exclusively through GFRα2 and, unlike GDNF, independently of TGFβ, distinguishing the two ligands' receptor-recruitment requirements.","evidence":"Receptor-specific neutralizing antibodies, radioligand binding, and neuronal survival assays in ciliary ganglion neurons","pmids":["17953664"],"confidence":"Medium","gaps":["Single-lab finding","Molecular basis of GFRα2 membrane recruitment not defined"]},{"year":2008,"claim":"Identified the specific retinal and intracellular signaling targets of NRTN—horizontal/amacrine cells via PI3K and MAPK rather than photoreceptors—clarifying which cell types carry the receptor complex.","evidence":"NRTN/RET knockout and conditional mice with electroretinography; chick retinosphere PI3K/MAPK pathway analysis","pmids":["18417692","18673446"],"confidence":"High","gaps":["Connection between pathway activation and specific functional output incomplete","Retinosphere is an in vitro model"]},{"year":2009,"claim":"Quantified NRTN's requirement for presynaptic cardiac cholinergic innervation and vagal control of heart rate, localizing its action to neuron maintenance rather than postsynaptic responsiveness.","evidence":"Nrtn knockout cardiac neuron counts, ACh measurement, vagal stimulation, and isolated atria pharmacology","pmids":["19176599"],"confidence":"High","gaps":["Trophic mechanism vs developmental specification not separated"]},{"year":2013,"claim":"Resolved an isoform-specific, transcription-independent signaling route: NRTN drives serine-727 STAT3 phosphorylation localized to mitochondria to support neurite outgrowth.","evidence":"Isoform-specific expression, dominant-negative STAT3 mutants, subcellular fractionation, and neurite outgrowth assays","pmids":["23872421"],"confidence":"Medium","gaps":["Single-lab finding","Mechanism by which mitochondrial P-Ser-STAT3 promotes outgrowth unresolved"]},{"year":2018,"claim":"Provided the first three-domain GFRα2 structure with NRTN and identified a heparan sulfate-binding site that modulates functional affinity through avidity and controls in vivo exposure.","evidence":"X-ray crystallography of NRTN and NRTN/GFRα2, mutagenesis, biophysical binding, and in vivo pharmacokinetics","pmids":["29414779"],"confidence":"High","gaps":["RET engagement not captured in this structure","Role of heparan sulfate in cellular signaling output not directly tested"]},{"year":2019,"claim":"Determined the architecture of the complete NRTN/GFRα2/RET extracellular complex, revealing the specific contacts and RET dimerization mode that enable kinase cross-phosphorylation, plus a tetramer that regulates RET endocytosis.","evidence":"Two independent cryo-EM structures of the reconstituted ternary complex with cell-based endocytosis assays","pmids":["31535977","31392261"],"confidence":"High","gaps":["Dynamics of tetramer formation in cells not fully resolved","Link between endocytosis and signaling duration not defined"]},{"year":2021,"claim":"Expanded NRTN beyond classical neurotrophism by establishing it as a muscle-secreted myokine that retrogradely specifies slow motor neuron identity while reprogramming muscle toward oxidative metabolism.","evidence":"Muscle-specific HSA-NRTN transgenic mice with RNA-seq of motor neuron somas and metabolic phenotyping; differential enteric neuron regulation by calcium imaging","pmids":["34592133","33444816"],"confidence":"High","gaps":["Receptor-level signaling mediating motor neuron specification not detailed","Whether endogenous NRTN performs this role at physiological levels untested"]},{"year":2022,"claim":"Identified non-neuronal trophic and immunomodulatory roles—an NRTN-dependent sympathetic-cholinergic/osteocyte survival interface in bone and dampening of macrophage inflammation downstream of interferon-induced receptor upregulation.","evidence":"Conditional/global knockout mice with micro-CT and exercise models in bone; human lung macrophage cultures with IFN stimulation and cytokine measurement","pmids":["35276096","33020210"],"confidence":"Medium","gaps":["Single-lab findings","Direct NRTN signaling readouts in macrophages and osteocytes limited"]},{"year":2024,"claim":"Demonstrated that NRTN signaling is hijacked across multiple cancers to drive proliferation, invasion, EMT, angiogenesis, and survival via GFRα2/RET and PI3K/AKT/mTOR.","evidence":"Knockdown/overexpression functional assays, xenograft/metastasis models, RET inhibition, and Co-IP across pancreatic, colorectal, hepatocellular, and AML systems","pmids":["24067900","31392261","29654265","35114191","37211171"],"confidence":"Medium","gaps":["Single-lab studies per tumor type","NRTN's specific contribution vs paracrine RET activation not always separated"]},{"year":2025,"claim":"Placed NRTN production downstream of Hedgehog/primary cilia signaling in striatal interneurons and astrocytes, connecting pathogenic LRRK2 to reduced NRTN and dopaminergic vulnerability, and identified BHLHE40 as a direct transcriptional repressor of NRTN in macrophages.","evidence":"LRRK2 mutant mice with MLi-2 treatment, cilia immunofluorescence, and Nrtn expression; ChIP-qPCR and luciferase promoter assays with in vivo asthma epistasis","pmids":["40591712","40467844"],"confidence":"Medium","gaps":["Causal chain from reduced NRTN to dopaminergic loss not directly tested by rescue","Single-lab transcriptional findings"]},{"year":null,"claim":"How NRTN's distinct cellular outcomes (survival, axon outgrowth, metabolic reprogramming, immunosuppression, oncogenic growth) are selected from a shared GFRα2/RET signaling core remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking signaling complex stoichiometry to context-specific output","Endogenous-level contributions in non-neuronal tissues largely inferred from gain-of-function"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,1,2,6]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,5]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[4,12,22]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,5,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,11,19]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,9,17]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[22,30]}],"complexes":["NRTN/GFRα2/RET ternary signaling complex"],"partners":["GFRA2","RET","GFRA1","TANGO1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q99748","full_name":"Neurturin","aliases":[],"length_aa":197,"mass_kda":22.4,"function":"Growth factor that supports the survival of sympathetic neurons in culture (PubMed:8945474). May regulate the development and maintenance of the CNS (PubMed:8945474). Involved in the development of the neural crest (PubMed:15242795). Might control the size of non-neuronal cell population such as haemopoietic cells (PubMed:8945474). Acts by binding to its coreceptor, GFRA2, leading to autophosphorylation and activation of the RET receptor (PubMed:10829012, PubMed:29414779, PubMed:31535977). Heparan sulfate-binding is required for signaling (PubMed:29414779)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q99748/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NRTN","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NRTN","total_profiled":1310},"omim":[{"mim_id":"605710","title":"GDNF FAMILY RECEPTOR ALPHA-3; GFRA3","url":"https://www.omim.org/entry/605710"},{"mim_id":"602921","title":"PERSEPHIN; PSPN","url":"https://www.omim.org/entry/602921"},{"mim_id":"602018","title":"NEURTURIN; NRTN","url":"https://www.omim.org/entry/602018"},{"mim_id":"601956","title":"GDNF FAMILY RECEPTOR ALPHA-2; GFRA2","url":"https://www.omim.org/entry/601956"},{"mim_id":"164761","title":"RET PROTOONCOGENE; RET","url":"https://www.omim.org/entry/164761"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"heart muscle","ntpm":18.9},{"tissue":"pancreas","ntpm":12.5}],"url":"https://www.proteinatlas.org/search/NRTN"},"hgnc":{"alias_symbol":["NTN"],"prev_symbol":[]},"alphafold":{"accession":"Q99748","domains":[{"cath_id":"2.10.90.10","chopping":"100-197","consensus_level":"medium","plddt":93.9051,"start":100,"end":197}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99748","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99748-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99748-F1-predicted_aligned_error_v6.png","plddt_mean":79.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NRTN","jax_strain_url":"https://www.jax.org/strain/search?query=NRTN"},"sequence":{"accession":"Q99748","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99748.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99748/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99748"}},"corpus_meta":[{"pmid":"12953054","id":"PMC_12953054","title":"Novel functions and signalling pathways for GDNF.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12953054","citation_count":477,"is_preprint":false},{"pmid":"10415156","id":"PMC_10415156","title":"Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse.","date":"1999","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10415156","citation_count":296,"is_preprint":false},{"pmid":"23528997","id":"PMC_23528997","title":"The developmental etiology and pathogenesis of Hirschsprung disease.","date":"2013","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23528997","citation_count":179,"is_preprint":false},{"pmid":"18394569","id":"PMC_18394569","title":"Treatment of Parkinson's disease with trophic factors.","date":"2008","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/18394569","citation_count":123,"is_preprint":false},{"pmid":"29710735","id":"PMC_29710735","title":"Gene Therapy for Parkinson's Disease, An Update.","date":"2018","source":"Journal of Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/29710735","citation_count":116,"is_preprint":false},{"pmid":"32508331","id":"PMC_32508331","title":"GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.","date":"2020","source":"Journal of Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/32508331","citation_count":110,"is_preprint":false},{"pmid":"10531437","id":"PMC_10531437","title":"Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific.","date":"1999","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10531437","citation_count":100,"is_preprint":false},{"pmid":"14507865","id":"PMC_14507865","title":"Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/14507865","citation_count":94,"is_preprint":false},{"pmid":"33444816","id":"PMC_33444816","title":"scRNA-Seq Reveals New Enteric Nervous System Roles for GDNF, NRTN, and TBX3.","date":"2021","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/33444816","citation_count":86,"is_preprint":false},{"pmid":"26616211","id":"PMC_26616211","title":"Current disease modifying approaches to treat Parkinson's disease.","date":"2015","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/26616211","citation_count":86,"is_preprint":false},{"pmid":"24067900","id":"PMC_24067900","title":"The neurotrophic factor neurturin contributes toward an aggressive cancer cell phenotype, neuropathic pain and neuronal plasticity in pancreatic cancer.","date":"2013","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24067900","citation_count":73,"is_preprint":false},{"pmid":"34907395","id":"PMC_34907395","title":"Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism.","date":"2021","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/34907395","citation_count":66,"is_preprint":false},{"pmid":"30947516","id":"PMC_30947516","title":"CDNF Protein Therapy in Parkinson's Disease.","date":"2019","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/30947516","citation_count":66,"is_preprint":false},{"pmid":"26450777","id":"PMC_26450777","title":"Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.","date":"2015","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/26450777","citation_count":63,"is_preprint":false},{"pmid":"10770848","id":"PMC_10770848","title":"Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat.","date":"2000","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/10770848","citation_count":62,"is_preprint":false},{"pmid":"34149364","id":"PMC_34149364","title":"Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain.","date":"2021","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34149364","citation_count":62,"is_preprint":false},{"pmid":"26176331","id":"PMC_26176331","title":"Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.","date":"2015","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26176331","citation_count":60,"is_preprint":false},{"pmid":"21196217","id":"PMC_21196217","title":"The spinal cord ependymal region: a stem cell niche in the caudal central nervous system.","date":"2011","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/21196217","citation_count":58,"is_preprint":false},{"pmid":"31535977","id":"PMC_31535977","title":"Cryo-EM analyses reveal the common mechanism and diversification in the activation of RET by different ligands.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31535977","citation_count":55,"is_preprint":false},{"pmid":"28442998","id":"PMC_28442998","title":"Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms.","date":"2017","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/28442998","citation_count":54,"is_preprint":false},{"pmid":"11585803","id":"PMC_11585803","title":"GDNF and neurturin are target-derived factors essential for cranial parasympathetic neuron development.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11585803","citation_count":54,"is_preprint":false},{"pmid":"35276096","id":"PMC_35276096","title":"A cholinergic neuroskeletal interface promotes bone formation during postnatal growth and exercise.","date":"2022","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/35276096","citation_count":53,"is_preprint":false},{"pmid":"29654265","id":"PMC_29654265","title":"RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia.","date":"2018","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/29654265","citation_count":53,"is_preprint":false},{"pmid":"16406089","id":"PMC_16406089","title":"Is GAS1 a co-receptor for the GDNF family of ligands?","date":"2006","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16406089","citation_count":51,"is_preprint":false},{"pmid":"26711317","id":"PMC_26711317","title":"Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer.","date":"2016","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26711317","citation_count":51,"is_preprint":false},{"pmid":"21704161","id":"PMC_21704161","title":"Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.","date":"2011","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/21704161","citation_count":47,"is_preprint":false},{"pmid":"32252363","id":"PMC_32252363","title":"Revisiting the Role of Neurotrophic Factors in Inflammation.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32252363","citation_count":45,"is_preprint":false},{"pmid":"25975578","id":"PMC_25975578","title":"The RET fusion gene and its correlation with demographic and clinicopathological features of non-small cell lung cancer: a meta-analysis.","date":"2015","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25975578","citation_count":45,"is_preprint":false},{"pmid":"34592133","id":"PMC_34592133","title":"Muscle-secreted neurturin couples myofiber oxidative metabolism and slow motor neuron identity.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34592133","citation_count":41,"is_preprint":false},{"pmid":"27545711","id":"PMC_27545711","title":"Proneurogenic Ligands Defined by Modeling Developing Cortex Growth Factor Communication Networks.","date":"2016","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/27545711","citation_count":37,"is_preprint":false},{"pmid":"11069590","id":"PMC_11069590","title":"Distinct roles for GFRalpha1 and GFRalpha2 signalling in different cranial parasympathetic ganglia in vivo.","date":"2000","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11069590","citation_count":36,"is_preprint":false},{"pmid":"32573073","id":"PMC_32573073","title":"The role of glial cell line-derived neurotrophic factor family member artemin in neurological disorders and cancers.","date":"2020","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/32573073","citation_count":36,"is_preprint":false},{"pmid":"23631873","id":"PMC_23631873","title":"Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120).","date":"2013","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/23631873","citation_count":35,"is_preprint":false},{"pmid":"12054525","id":"PMC_12054525","title":"Caenorhabditis elegans reticulon interacts with RME-1 during embryogenesis.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12054525","citation_count":34,"is_preprint":false},{"pmid":"16708241","id":"PMC_16708241","title":"Localization of cholinergic innervation and neurturin receptors in adult mouse heart and expression of the neurturin gene.","date":"2006","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/16708241","citation_count":33,"is_preprint":false},{"pmid":"11050250","id":"PMC_11050250","title":"Development and persistence of kindling epilepsy are impaired in mice lacking glial cell line-derived neurotrophic factor family receptor alpha 2.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11050250","citation_count":33,"is_preprint":false},{"pmid":"22216140","id":"PMC_22216140","title":"Phenotypic switching of nonpeptidergic cutaneous sensory neurons following peripheral nerve injury.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22216140","citation_count":32,"is_preprint":false},{"pmid":"29414779","id":"PMC_29414779","title":"Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signaling.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29414779","citation_count":30,"is_preprint":false},{"pmid":"32556722","id":"PMC_32556722","title":"Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson's disease.","date":"2020","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/32556722","citation_count":29,"is_preprint":false},{"pmid":"31392261","id":"PMC_31392261","title":"Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31392261","citation_count":28,"is_preprint":false},{"pmid":"19176599","id":"PMC_19176599","title":"Structural and functional cardiac cholinergic deficits in adult neurturin knockout mice.","date":"2009","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/19176599","citation_count":26,"is_preprint":false},{"pmid":"18417692","id":"PMC_18417692","title":"Neurturin-mediated ret activation is required for retinal function.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18417692","citation_count":25,"is_preprint":false},{"pmid":"15629763","id":"PMC_15629763","title":"Expression and function of GDNF family ligands and receptors in the carotid body.","date":"2005","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15629763","citation_count":25,"is_preprint":false},{"pmid":"22961804","id":"PMC_22961804","title":"Neuronal plasticity in chronic pancreatitis is mediated via the neurturin/GFRα2 axis.","date":"2012","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22961804","citation_count":23,"is_preprint":false},{"pmid":"23365243","id":"PMC_23365243","title":"Neurturin overexpression in skin enhances expression of TRPM8 in cutaneous sensory neurons and leads to behavioral sensitivity to cool and menthol.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23365243","citation_count":22,"is_preprint":false},{"pmid":"22525569","id":"PMC_22525569","title":"Translating the therapeutic potential of neurotrophic factors to clinical 'proof of concept': a personal saga achieving a career-long quest.","date":"2012","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/22525569","citation_count":21,"is_preprint":false},{"pmid":"17953664","id":"PMC_17953664","title":"Specificity in the crosstalk of TGFbeta/GDNF family members is determined by distinct GFR alpha receptors.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17953664","citation_count":19,"is_preprint":false},{"pmid":"32319659","id":"PMC_32319659","title":"RET receptor expression and interaction with TRK receptors in neuroblastomas.","date":"2020","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/32319659","citation_count":16,"is_preprint":false},{"pmid":"22150630","id":"PMC_22150630","title":"Human-protein-derived peptides for intracellular delivery of biomolecules.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22150630","citation_count":15,"is_preprint":false},{"pmid":"34170009","id":"PMC_34170009","title":"Glial-derived neurotrophic factor in human airway smooth muscle.","date":"2021","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34170009","citation_count":13,"is_preprint":false},{"pmid":"11694339","id":"PMC_11694339","title":"Transient disruption of spermatogenesis by deregulated expression of neurturin in testis.","date":"2001","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11694339","citation_count":13,"is_preprint":false},{"pmid":"17509555","id":"PMC_17509555","title":"Neurturin-GFRalpha2 signaling controls liver bud migration along the ductus venosus in the chick embryo.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17509555","citation_count":13,"is_preprint":false},{"pmid":"35434281","id":"PMC_35434281","title":"The RET gene encodes RET protein, which triggers intracellular signaling pathways for enteric neurogenesis, and RET mutation results in Hirschsprung's disease.","date":"2022","source":"AIMS neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35434281","citation_count":12,"is_preprint":false},{"pmid":"39744838","id":"PMC_39744838","title":"Single-Cell Transcriptomics Identifies Selective Lineage-Specific Regulation of Genes in Aortic Smooth Muscle Cells in Mice.","date":"2025","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/39744838","citation_count":11,"is_preprint":false},{"pmid":"33935108","id":"PMC_33935108","title":"GDNF Therapy: Can We Make It Work?","date":"2021","source":"Journal of Parkinson's disease","url":"https://pubmed.ncbi.nlm.nih.gov/33935108","citation_count":11,"is_preprint":false},{"pmid":"31678350","id":"PMC_31678350","title":"Focal and dose-dependent neuroprotection in ALS mice following AAV2-neurturin delivery.","date":"2019","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31678350","citation_count":11,"is_preprint":false},{"pmid":"28408435","id":"PMC_28408435","title":"Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats.","date":"2017","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/28408435","citation_count":11,"is_preprint":false},{"pmid":"37211171","id":"PMC_37211171","title":"TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K/AKT/mTOR signaling pathway.","date":"2023","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37211171","citation_count":10,"is_preprint":false},{"pmid":"35114191","id":"PMC_35114191","title":"Neurturin promotes tumor cell motility and angiogenesis in colorectal cancer.","date":"2022","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/35114191","citation_count":10,"is_preprint":false},{"pmid":"23872421","id":"PMC_23872421","title":"GDNF family ligand dependent STAT3 activation is mediated by specific alternatively spliced isoforms of GFRα2 and RET.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23872421","citation_count":10,"is_preprint":false},{"pmid":"32725425","id":"PMC_32725425","title":"Improving therapeutic potential of GDNF family ligands.","date":"2020","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/32725425","citation_count":10,"is_preprint":false},{"pmid":"16193278","id":"PMC_16193278","title":"GDNF family ligand immunoreactivity in the gut of teleostean fish.","date":"2005","source":"Anatomy and embryology","url":"https://pubmed.ncbi.nlm.nih.gov/16193278","citation_count":9,"is_preprint":false},{"pmid":"12478607","id":"PMC_12478607","title":"Developmental expression of glial cell-line derived neurotrophic factor, neurturin, and their receptor mRNA in the rat urinary bladder.","date":"2003","source":"Neurourology and urodynamics","url":"https://pubmed.ncbi.nlm.nih.gov/12478607","citation_count":9,"is_preprint":false},{"pmid":"24657391","id":"PMC_24657391","title":"Effect of neurturin deficiency on cholinergic and catecholaminergic innervation of the murine eye.","date":"2014","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/24657391","citation_count":8,"is_preprint":false},{"pmid":"33020210","id":"PMC_33020210","title":"Neurturin regulates the lung-resident macrophage inflammatory response to viral infection.","date":"2020","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/33020210","citation_count":8,"is_preprint":false},{"pmid":"40591712","id":"PMC_40591712","title":"Restoration of striatal neuroprotective pathways by kinase inhibitor treatment of Parkinson's disease-linked LRRK2-mutant mice.","date":"2025","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/40591712","citation_count":7,"is_preprint":false},{"pmid":"37285682","id":"PMC_37285682","title":"Multi-omics study of key genes, metabolites, and pathways of periodontitis.","date":"2023","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/37285682","citation_count":7,"is_preprint":false},{"pmid":"25882529","id":"PMC_25882529","title":"Peptide based DNA nanocarriers incorporating a cell-penetrating peptide derived from neurturin protein and poly-L-lysine dendrons.","date":"2015","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25882529","citation_count":7,"is_preprint":false},{"pmid":"37934784","id":"PMC_37934784","title":"Whole genome sequencing of 4,787 individuals identifies gene-based rare variants in age-related macular degeneration.","date":"2024","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37934784","citation_count":7,"is_preprint":false},{"pmid":"40737317","id":"PMC_40737317","title":"Lysosomal glucocerebrosidase is needed for ciliary Hedgehog signaling: A convergent pathway contributing to Parkinson's disease.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40737317","citation_count":6,"is_preprint":false},{"pmid":"40133606","id":"PMC_40133606","title":"Deciphering genetic causality between plasma BDNF and 91 circulating inflammatory proteins through bidirectional mendelian randomization.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40133606","citation_count":6,"is_preprint":false},{"pmid":"18673446","id":"PMC_18673446","title":"Neurturin, a member of the glial cell line-derived neurotrophic factor family, affects the development of acetylcholinesterase-positive cells in a three-dimensional model system of retinogenesis.","date":"2008","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18673446","citation_count":6,"is_preprint":false},{"pmid":"37958856","id":"PMC_37958856","title":"Expression of Glial-Cell-Line-Derived Neurotrophic Factor Family Ligands in Human Intervertebral Discs.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37958856","citation_count":5,"is_preprint":false},{"pmid":"40778592","id":"PMC_40778592","title":"Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions.","date":"2025","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/40778592","citation_count":5,"is_preprint":false},{"pmid":"32767110","id":"PMC_32767110","title":"Plasma membrane localization of the GFL receptor components: a nexus for receptor crosstalk.","date":"2020","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/32767110","citation_count":5,"is_preprint":false},{"pmid":"40474233","id":"PMC_40474233","title":"Sympathetic cholinergic nerve fibres promote BMSC differentiation into osteoblasts via NRTN secretion: a potential treatment for osteoporosis.","date":"2025","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/40474233","citation_count":3,"is_preprint":false},{"pmid":"40923287","id":"PMC_40923287","title":"The Role of Gut Microbiota on Idiopathic Pulmonary Fibrosis Mediated by Circulating Inflammatory Proteins: A Two-Step, Two-Sample Mendelian Randomization Study.","date":"2025","source":"The clinical respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/40923287","citation_count":3,"is_preprint":false},{"pmid":"40467844","id":"PMC_40467844","title":"BHLHE40 contributes to allergic asthma progression in mice through NRTN downregulation in macrophages.","date":"2025","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/40467844","citation_count":2,"is_preprint":false},{"pmid":"37671183","id":"PMC_37671183","title":"Sputum Neurturin Levels in Adult Asthmatic Subjects.","date":"2023","source":"Journal of asthma and allergy","url":"https://pubmed.ncbi.nlm.nih.gov/37671183","citation_count":2,"is_preprint":false},{"pmid":"40627758","id":"PMC_40627758","title":"Causal network between periodontitis and systemic inflammation: Triangulating evidence from Mendelian randomization and sequencing datasets.","date":"2025","source":"Journal of periodontology","url":"https://pubmed.ncbi.nlm.nih.gov/40627758","citation_count":2,"is_preprint":false},{"pmid":"40305235","id":"PMC_40305235","title":"Proteomic Profiling of Inflammatory Protein Dysregulation in HLA-B27-Positive Ankylosing Spondylitis: Molecular Signatures and Potential Biomarkers.","date":"2025","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40305235","citation_count":2,"is_preprint":false},{"pmid":"35509264","id":"PMC_35509264","title":"Reawakening GDNF's regenerative past in mice and humans.","date":"2022","source":"Regenerative therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35509264","citation_count":2,"is_preprint":false},{"pmid":"40426929","id":"PMC_40426929","title":"Modulation of Neurturin Expression by Lumbosacral Spinal Stenosis, Lifestyle Factors, and Glycemic Dysregulation.","date":"2025","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/40426929","citation_count":2,"is_preprint":false},{"pmid":"40481130","id":"PMC_40481130","title":"Identification of immune-associated genes and single-cell sequencing analysis in diagnosing Behçet's disease.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40481130","citation_count":1,"is_preprint":false},{"pmid":"39122143","id":"PMC_39122143","title":"Neurturin GF Enhances the Acute Cytokine Response of Inflamed Skin.","date":"2024","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/39122143","citation_count":1,"is_preprint":false},{"pmid":"30207219","id":"PMC_30207219","title":"Cellular, Molecular and Non-Pharmacological Therapeutic Advances for the Treatment of Parkinson's Disease: Separating Hope from Hype.","date":"2018","source":"Current gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30207219","citation_count":1,"is_preprint":false},{"pmid":"40697816","id":"PMC_40697816","title":"Plasma protein biomarkers of Plasmodium falciparum infection in pregnant women: a high-throughput proteomics study.","date":"2025","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/40697816","citation_count":1,"is_preprint":false},{"pmid":"39671698","id":"PMC_39671698","title":"Neurturin gene IVSI-663 polymorphism but not RET variants is associated with increased risk for breast cancer.","date":"2025","source":"Laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39671698","citation_count":1,"is_preprint":false},{"pmid":"38219812","id":"PMC_38219812","title":"The effects of induced type I diabetes on developmental regulation of GDNF, NRTN, and NCAM proteins in the dentate gyrus of male rat offspring.","date":"2024","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/38219812","citation_count":0,"is_preprint":false},{"pmid":"39252214","id":"PMC_39252214","title":"Association of MCP-4, NRTN, and PD-L1 with the risk of hepatic fibrosis: A Mendelian randomization study.","date":"2024","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39252214","citation_count":0,"is_preprint":false},{"pmid":"40686838","id":"PMC_40686838","title":"Single-Cell Transcriptome Analyses of Four Pain Related Genes in Osteosarcoma.","date":"2025","source":"Cancer informatics","url":"https://pubmed.ncbi.nlm.nih.gov/40686838","citation_count":0,"is_preprint":false},{"pmid":"39056435","id":"PMC_39056435","title":"Spatiotemporal regulation of dental pulpal innervation in the rat.","date":"2024","source":"Anatomia, histologia, embryologia","url":"https://pubmed.ncbi.nlm.nih.gov/39056435","citation_count":0,"is_preprint":false},{"pmid":"41837837","id":"PMC_41837837","title":"Gene therapy for Parkinson's disease: current landscape, translational challenges, and future directions.","date":"2026","source":"Expert review of neurotherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/41837837","citation_count":0,"is_preprint":false},{"pmid":"41224187","id":"PMC_41224187","title":"Suppression of HIF-1α alleviates the symptoms associated with diabetic retinopathy in mice.","date":"2025","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/41224187","citation_count":0,"is_preprint":false},{"pmid":"41047677","id":"PMC_41047677","title":"Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study.","date":"2025","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41047677","citation_count":0,"is_preprint":false},{"pmid":"41065791","id":"PMC_41065791","title":"Inflammatory Proteins Profiling in Tear Fluid in Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration.","date":"2025","source":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/41065791","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.09.681259","title":"CNTF specifically slows down the axonal transport of signalling endosomes","date":"2025-10-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.09.681259","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.20.633968","title":"Lysosomal Glucocerebrosidase is needed for ciliary Hedgehog signaling: A convergent pathway to Parkinson’s disease","date":"2025-01-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.20.633968","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.31.606089","title":"Restoration of striatal neuroprotective pathways by kinase inhibitor treatment of Parkinsons linked-LRRK2 mutant mice","date":"2024-08-03","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.31.606089","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52107,"output_tokens":8785,"usd":0.144048,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18819,"output_tokens":4502,"usd":0.103322,"stage2_stop_reason":"end_turn"},"total_usd":0.24737,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"Cryo-EM structure of the NRTN/GFRα2/RET extracellular ternary complex revealed that NRTN and GFRα2 induce a specific dimerization mode of RET that brings two kinase domains into proximity for cross-phosphorylation. The NRTN/GFRα2/RET dimeric complex further packs into a tetrameric assembly, and cell-based assays showed this tetramer regulates RET endocytosis.\",\n      \"method\": \"Cryo-EM structure determination; cell-based endocytosis assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure with functional validation by cell-based assay; multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"31535977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cryo-EM structure of the complete extracellular RET signaling complex with NRTN and GFRα2 (5.7 Å) identified two key interaction points: (i) the calcium-binding site in RET contacts GFRα2 domain 3, and (ii) the RET cysteine-rich domain directly interacts with NRTN. This structure provides a model for how ternary complex formation leads to RET dimerization and activation.\",\n      \"method\": \"Cryo-EM structure determination (reconstituted full extracellular complex)\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution of complete extracellular complex and cryo-EM structure; independently consistent with parallel eLife 2019 study\",\n      \"pmids\": [\"31392261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of NRTN alone and in complex with GFRα2 (first structure of a GFRα with all three domains) showed that GFRα2 domain 1 does not interact directly with NRTN but may support interaction with RET/NCAM via a conserved surface. A heparan sulfate-binding site was identified on NRTN, and biophysical data showed relative GFRα2 concentration on cell surfaces affects NRTN functional affinity through avidity. A NRTN mutant with reduced heparan sulfate affinity showed increased in vivo exposure.\",\n      \"method\": \"X-ray crystallography; biophysical binding assays; mutagenesis; in vivo pharmacokinetic studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with mutagenesis and biophysical assays, multiple orthogonal methods in one study\",\n      \"pmids\": [\"29414779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"After sciatic nerve injection, NRTN was retrogradely transported by two populations of dorsal root ganglion sensory neurons: a major population of small, RET+/IB4+/non-TrkA neurons that also transport GDNF, and a minor calretinin-expressing population that does not transport GDNF. Cross-competition studies showed only limited competition between NRTN and GDNF, indicating GFRα coreceptor-specific transport in vivo.\",\n      \"method\": \"In vivo retrograde transport assay; immunohistochemistry; competition experiments\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct in vivo retrograde transport experiments with competition controls; replicated across multiple neuronal populations\",\n      \"pmids\": [\"10531437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GDNF and NRTN are target-derived factors for developing ciliary ganglion neurons. GDNF and NRTN are secreted from eye muscle (the target tissue) during the period of ciliary axon innervation. In vitro and in vivo function-blocking of GDNF at early embryonic ages suppressed ciliary axon outgrowth. After GDNF expression declines in the target, GFRα1 and RET (but not GFRα2) are downregulated in innervating neurons, suggesting target-derived GDNF regulates coreceptor expression.\",\n      \"method\": \"In vitro and in vivo function-blocking antibody assays; in situ hybridization; immunohistochemistry\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — both in vitro and in vivo function-blocking with consistent results; defined target-derived mechanism\",\n      \"pmids\": [\"11585803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NRTN signals through GFRα2c and RET9 isoforms specifically to induce serine-727 (but not tyrosine-705) phosphorylation of STAT3 in neurons. A serine-dominant-negative STAT3 mutant impaired NRTN-induced neurite outgrowth, while a tyrosine-dominant-negative mutant did not. Mitochondrially localized P-Ser-STAT3 was identified as the downstream mediator of NRTN-induced neurite outgrowth (transcription-independent mechanism).\",\n      \"method\": \"Isoform-specific expression; dominant-negative mutagenesis; phospho-specific immunoblotting; subcellular fractionation; neurite outgrowth assays\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (mutagenesis, fractionation, functional assay) from a single lab\",\n      \"pmids\": [\"23872421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In ciliary ganglion neurons, NRTN promotes survival exclusively via its cognate receptor GFRα2 (demonstrated by receptor-specific neutralizing antibodies), and unlike GDNF, NRTN-mediated survival and signaling does not require TGFβ. TGFβ does not promote recruitment of GFRα2 to the plasma membrane (in contrast to GFRα1), and disruption of TGFβ signaling does not impair NRTN-mediated survival.\",\n      \"method\": \"Receptor-specific neutralizing antibody assays; radioligand binding; immunocytochemistry; neuronal survival assays\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (binding, survival, antibody blocking) from a single lab; distinct mechanistic contrast with GDNF established\",\n      \"pmids\": [\"17953664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NRTN-deficient (NRTN−/−) mice show reduced aqueous tear production, corneal sensation, mucin expression, and goblet cell density, with increased ocular surface inflammation (elevated IL-1β, TNF-α, MMP-9), demonstrating NRTN is required for parasympathetic innervation of the lacrimal gland and maintenance of ocular surface homeostasis.\",\n      \"method\": \"Knockout mouse phenotyping; tear function assays; immunofluorescence; ELISA; zymography; RT-PCR\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with multiple orthogonal functional readouts; well-controlled study\",\n      \"pmids\": [\"14507865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NRTN knockout mice contain only 35% the normal number of cardiac cholinergic neurons (15% smaller), with 87% reduction in cholinergic nerve density at the sinoatrial node, substantially lower atrial acetylcholine, and reduced vagal bradycardia. Post-junctional sensitivity to muscarinic agonists was normal, placing NRTN's role specifically in maintaining presynaptic cholinergic innervation and cholinergic control of heart rate.\",\n      \"method\": \"Nrtn knockout mouse; immunohistochemistry; confocal microscopy; quantitative image analysis; ACh measurement; vagal nerve stimulation; isolated atria pharmacology\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with multiple orthogonal functional and structural readouts; clear mechanistic placement\",\n      \"pmids\": [\"19176599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NRTN deficiency (knockout mice) led to diminished scotopic and photopic electroretinogram responses, thinning of the outer plexiform layer, reduction in horizontal cell dendrites and axons, and mislocalized synaptic complexes. GFRα2 expression was restricted to a subset of amacrine and ganglion cells; photoreceptors and Müller cells did not express GFRα1, GFRα2, or RET, indicating NRTN/RET signaling acts on horizontal and amacrine cells rather than photoreceptors.\",\n      \"method\": \"Electroretinography; NRTN/RET knockout and conditional mice; fluorescence reporter expression mapping; morphologic analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple knockout models with electroretinography and detailed anatomical analyses; clear target cell identification\",\n      \"pmids\": [\"18417692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NRTN mRNA is expressed in smooth muscle of penile blood vessels and corpus cavernosum; GFRα2 and RET mRNAs are expressed in virtually all major pelvic ganglion neurons. 125I-NRTN injected into the penis was retrogradely transported to major pelvic and dorsal root ganglia. GFRα2-deficient mice had significantly fewer NOS-containing nerve fibers in penile nerves, establishing NRTN as a target-derived trophic factor for penile erection-inducing parasympathetic neurons via GFRα2/RET.\",\n      \"method\": \"In situ hybridization; radioligand retrograde transport assay; GFRα2 knockout immunohistochemistry\",\n      \"journal\": \"Journal of neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — retrograde transport assay plus genetic knockout; single lab, two complementary methods\",\n      \"pmids\": [\"10770848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GFRα2-deficient mice show normal early gangliogenesis in cranial parasympathetic ganglia but postnatal amplification of neuron loss and atrophy in submandibular and otic ganglia, accompanied by complete loss of target innervation. Sphenopalatine neurons were not reduced numerically despite complete loss of target innervation. This establishes that NRTN/GFRα2/RET signaling is essential for the development and maintenance of parasympathetic target innervation (distinct from GDNF/GFRα1/RET, which is required for early gangliogenesis).\",\n      \"method\": \"GFRα1, GFRα2, and RET knockout mouse histology; in situ hybridization; immunohistochemistry\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis across multiple knockout lines with quantitative anatomical readouts; clear pathway placement\",\n      \"pmids\": [\"11069590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Muscle-derived NRTN acts as a myokine that signals retrogradely to motor neurons to promote slow motor neuron identity (RNA sequencing of motor neuron somas from HSA-NRTN transgenic mice). In muscle, NRTN increased capillary density, oxidative capacity, and induced transcriptional reprogramming toward fatty acid metabolism. HSA-NRTN mice phenocopied muscle-specific PGC-1α1 overexpression.\",\n      \"method\": \"Muscle-specific NRTN transgenic mice; RNA sequencing of motor neuron somas; metabolic phenotyping; immunohistochemistry\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic gain-of-function model with RNA-seq and multiple physiological readouts; novel myokine mechanism established\",\n      \"pmids\": [\"34592133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Calcium imaging combined with differential Gfra1 and Gfra2 expression analysis in enteric neurons showed that GDNF and NRTN acutely and differentially regulate activity of ~50% of myenteric neurons, with distinct effects on smooth muscle contractions.\",\n      \"method\": \"Single-nucleus/single-cell RNA-seq; calcium imaging; immunohistochemistry; conditional knockout mice\",\n      \"journal\": \"Cellular and molecular gastroenterology and hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — calcium imaging with RNA-seq validation; single study but two orthogonal methods\",\n      \"pmids\": [\"33444816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Sympathetic cholinergic nerve fibers establish a neurotrophic dependency with bone-embedded osteocytes via NRTN/GFRα2. An IL-6-induced cholinergic switch in sympathetic fibers occurs postnatally upon bone contact, and osteocytes require cholinergic innervation for survival and connectivity. Loss of cholinergic skeletal innervation caused osteopenia and impaired skeletal adaptation to exercise, establishing a NRTN-dependent neuro-osteocyte interface.\",\n      \"method\": \"Conditional and global knockout mice; lineage tracing; immunohistochemistry; micro-CT; exercise models\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with multiple functional readouts; single lab\",\n      \"pmids\": [\"35276096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In pancreatic cancer cells, NRTN promoted proliferation and invasion via GFRα2. siRNA silencing of NRTN limited PCC proliferation and invasion. Depletion of NRTN from cancer tissue extracts and PCC supernatants decreased axonal sprouting in neuronal cultures. Paradoxically, NRTN silencing in PCCs boosted neural invasion.\",\n      \"method\": \"siRNA knockdown; MTT viability assay; Matrigel invasion assay; in vitro neuroplasticity assay; 3D neural migration assay; immunohistochemistry; qRT-PCR; immunoblotting\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple in vitro functional assays with knockdown; single lab\",\n      \"pmids\": [\"24067900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In chronic pancreatitis, NRTN/GFRα2 axis is activated (upregulated mature multimeric NRTN and elevated GFRα2). Depletion of NRTN from chronic pancreatitis tissue extracts using blocking antibodies reduced neurotrophic effects on DRG neurons in vitro (decreased axonal sprouting), while NRTN depletion did not affect glial cell density, establishing NRTN as a key mediator of reactive neural alterations in chronic pancreatitis.\",\n      \"method\": \"Immunohistochemistry; immunoblotting; qRT-PCR; in vitro neuroplasticity assay with NRTN depletion\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — depletion experiments in ex vivo assay combined with human tissue analysis; single lab\",\n      \"pmids\": [\"22961804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NRTN overexpression in keratinocytes (NRTN-OE mice) increased density of PGP9.5-positive free nerve endings, hypertrophied GFRα2-immunopositive sensory neuron somas, increased mRNAs for GFRα2, RET, P2X3, ASIC2a, and TRPM8 in sensory ganglia, and elevated behavioral sensitivity to mechanical stimuli, cool temperature, and menthol. The increase in cool/menthol sensitivity correlated directly with elevated TRPM8 expression.\",\n      \"method\": \"Transgenic NRTN overexpression; immunohistochemistry; electron microscopy; RT-PCR; behavioral testing; calcium imaging\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic gain-of-function with multiple orthogonal molecular and behavioral readouts; well-controlled study\",\n      \"pmids\": [\"23365243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In adult mouse heart, NRTN mRNA is expressed in atrial and ventricular tissue, and >90% of cardiac parasympathetic ganglion neurons express both RET and GFRα2 (the NRTN receptor complex). GFRα2 is present in most cholinergic nerve fibers and Schwann cells, with some cholinergic sinoatrial node fibers also expressing RET, suggesting ongoing neurotrophic support of adult cardiac cholinergic innervation by NRTN.\",\n      \"method\": \"RT-PCR; immunohistochemistry; confocal microscopy\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization study linking NRTN receptor expression to specific cardiac neural populations; multiple methods but no functional manipulation\",\n      \"pmids\": [\"16708241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In chick embryo liver development, NRTN is expressed in endothelial cells of the ductus venosus while GFRα2 is expressed in the liver bud. Inhibition of GFRα2 signaling suppressed liver bud elongation along the ductus venosus without affecting cell proliferation or apoptosis. Ectopic NRTN expression perturbed directional migration. In vitro, liver buds selectively migrated toward NRTN-soaked beads, establishing NRTN as a chemoattractant for GFRα2-expressing liver bud cells.\",\n      \"method\": \"In situ hybridization; GFRα2 signaling inhibition in ovo; ectopic NRTN expression; in vitro bead chemotaxis assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — function-blocking and gain-of-function in vivo plus in vitro chemotaxis; single lab with two orthogonal approaches\",\n      \"pmids\": [\"17509555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Seizure activity regulates GFRα2 gene expression in limbic structures, and mice lacking GFRα2 show markedly suppressed epileptogenesis in the hippocampal kindling model, with lower hyperexcitability at 6–8 weeks post-kindling. This places NRTN signaling through GFRα2 as a modulator of seizure susceptibility, potentially via hilar neuropeptide Y-containing interneurons and entorhinal cortical afferents.\",\n      \"method\": \"GFRα2 knockout mice; hippocampal kindling electrophysiology; in situ hybridization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with electrophysiological readout; single lab; pathway placement somewhat indirect\",\n      \"pmids\": [\"11050250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"After peripheral nerve injury, GFRα2-positive cutaneous sensory neurons (normally NRTN-responsive) switch phenotype: GFRα2 immunoreactivity is rapidly lost and neurons begin expressing GFRα3 and TRPV1. NRTN failed to prevent neuronal death or ATF3 upregulation in vitro, while NGF and ARTN succeeded, correlating with the loss of GFRα2. This switch was correlated with downregulation of the transcription factor Runx1.\",\n      \"method\": \"Retrograde labeling; nerve cut injury; in vitro survival/ATF3 assays with GFL treatment; immunohistochemistry; RT-PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — injury model with in vitro functional validation and transcription factor correlation; single lab, multiple methods\",\n      \"pmids\": [\"22216140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Human lung-resident macrophages express GFRα2 and RET; type I interferon upregulates RET on macrophages. Epithelial-derived NRTN binding to the GFRα2/RET complex on macrophages dampens pro-inflammatory cytokine release and modulates matrix metalloproteinase production in response to viral stimuli, establishing a non-neuronal immunomodulatory role for NRTN in lung macrophages.\",\n      \"method\": \"Human lung macrophage cultures; cytokine measurement (ELISA); type I IFN stimulation; receptor expression analysis\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional ex vivo experiments in human cells with mechanistic receptor identification; single lab\",\n      \"pmids\": [\"33020210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TANGO1 interacts with NRTN in hepatocellular carcinoma cells (validated by endogenous Co-IP and confocal colocalization), and both proteins promote HCC progression by activating the PI3K/AKT/mTOR signaling pathway.\",\n      \"method\": \"Endogenous Co-immunoprecipitation; confocal colocalization; RNA-seq; knockdown functional assays\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP and colocalization with pathway analysis; single lab, limited mechanistic depth on NRTN's specific role\",\n      \"pmids\": [\"37211171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"AML cells activate RET signaling via NRTN/GFRα2 ligand/co-receptor complexes. Downstream, RET activates mTORC1-mediated autophagy suppression, which stabilizes leukemogenic drivers such as mutant FLT3. Genetic or pharmacologic RET inhibition impaired AML growth and was accompanied by upregulation of autophagy and FLT3 depletion.\",\n      \"method\": \"Functional genomic screen; co-receptor expression analysis; RET inhibition (genetic and pharmacologic); autophagy and FLT3 assays; mouse AML models; primary patient samples\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple experimental models (cell lines, mouse, primary patient) with pathway validation; NRTN/GFRα2 identified as the activating ligand/co-receptor complex for RET in AML\",\n      \"pmids\": [\"29654265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In chicken retinospheres (3D model), exogenous NRTN activated PI3K and MAPK signaling pathways, with MAPK activation localizing specifically to acetylcholinesterase-positive cells in the innermost rows of the inner nuclear layer. NRTN application increased the number of acetylcholinesterase-positive cells at late culture stages; Müller glia did not express GFRα2 and were not involved in NRTN signaling.\",\n      \"method\": \"3D retinosphere culture; exogenous NRTN treatment; signaling pathway analysis (phospho-specific antibodies); immunohistochemistry; cell counting\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assay with pathway activation and cell-type-specific analysis; single lab, in vitro model\",\n      \"pmids\": [\"18673446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NRTN and GDNF were identified as proneurogenic ligands in the embryonic cortex: cortical neurons (but not neural precursor cells) secrete factors promoting NPC differentiation, and NRTN promotes neurogenic differentiation of NPCs in vivo.\",\n      \"method\": \"Transcriptome profiling; cell-surface mass spectrometry; computational modeling; in vivo neurogenesis assays\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — in vivo functional validation mentioned but method detail is limited in abstract; single study\",\n      \"pmids\": [\"27545711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Pathogenic LRRK2 mutations inhibit primary cilia formation in striatal cholinergic/parvalbumin interneurons and astrocytes, blocking Hedgehog signaling and reducing GDNF and NRTN production. MLi-2 LRRK2 inhibitor treatment restored primary cilia, Hedgehog-responsive Gdnf and Nrtn expression, and striatal dopaminergic process density.\",\n      \"method\": \"LRRK2 mutant mice; dietary MLi-2 treatment; immunofluorescence for cilia; gene expression analysis; dopaminergic axon density quantification\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological manipulation with multiple functional readouts; establishes NRTN production as downstream of Hedgehog/cilia signaling in striatum\",\n      \"pmids\": [\"40591712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NRTN when injected intramuscularly alongside tetanus neurotoxin fragment (HcT) to track signaling endosome transport in motor neurons in vivo produced no detectable change in retrograde endosome transport dynamics in either fast or slow motor neurons (negative result), in contrast to CNTF which markedly slowed endosome transport.\",\n      \"method\": \"In vivo intramuscular injection; live imaging of sciatic nerve axonal transport in anaesthetised mice; fluorescent HcT endosome tracking\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — rigorous in vivo imaging assay; negative result for NRTN specifically; preprint, not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Subcutaneous NRTN administration to Zucker diabetic fatty rats prevented hyperglycemia, increased pancreatic insulin content and β-cell mass, and preserved islet organization. Acute NRTN treatment did not activate c-Fos in brain feeding centers or directly enhance glucose-stimulated insulin secretion from isolated β-cells, indicating the antidiabetic effect is not mediated through central appetite regulation or direct β-cell insulin secretion.\",\n      \"method\": \"In vivo subcutaneous administration in ZDF rats; c-Fos immunohistochemistry in brain; isolated β-cell glucose-stimulated insulin secretion assay; metabolic phenotyping\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo model with mechanistic exclusion experiments (central c-Fos, direct β-cell assay); single lab\",\n      \"pmids\": [\"28408435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BHLHE40 binds to the NRTN promoter (confirmed by ChIP-qPCR and dual luciferase assay) and reduces NRTN transcriptional activity in macrophages. In OVA-challenged asthmatic mice, simultaneous knockdown of Bhlhe40 and Nrtn recovered alternative macrophage activation and rescued the asthma phenotype, placing NRTN as a downstream transcriptional target of BHLHE40 that promotes M2 macrophage activation.\",\n      \"method\": \"Dual luciferase promoter assay; ChIP-qPCR; siRNA knockdown in vivo and in vitro; OVA asthma mouse model; macrophage polarization assays\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter-binding evidence plus in vivo epistasis; single lab\",\n      \"pmids\": [\"40467844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In colorectal cancer cells, NRTN promoted migration/invasion by upregulating ZEB1 and N-cadherin (EMT markers) and promoted angiogenesis by upregulating VEGF-A. NRTN inhibition prevented CRC metastasis and angiogenesis in vivo.\",\n      \"method\": \"siRNA/overexpression functional assays; migration/invasion assays; endothelial tube formation; in vivo xenograft/metastasis models; Western blotting\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo functional experiments with molecular mechanism identification; single lab\",\n      \"pmids\": [\"35114191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Targeted overexpression of NRTN in mouse testis caused transient degeneration of spermatids and pachytene spermatocytes between 3–5 weeks of age (in ~20% of transgenic lines), with no defect after 5 weeks and normal fertility, suggesting NRTN may regulate survival/differentiation of spermatocytes and spermatids but is not essential for spermatogenesis.\",\n      \"method\": \"Testis-specific NRTN transgenic mice; histology; phenotypic analysis\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single gain-of-function transgenic approach; low penetrance limits mechanistic conclusions\",\n      \"pmids\": [\"11694339\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NRTN is a secreted homodimeric member of the GDNF family that signals canonically by first binding its GPI-anchored co-receptor GFRα2 (and less selectively GFRα1); the NRTN/GFRα2 complex then recruits and dimerizes the RET receptor tyrosine kinase (with a key RET cysteine-rich domain–NRTN contact and a calcium-binding–GFRα2 domain 3 contact), driving RET kinase cross-phosphorylation and downstream activation of PI3K, MAPK, and isoform-specific STAT3 (serine-727, mitochondria-localized) pathways; the NRTN/GFRα2/RET ternary complex can further assemble into a tetramer that regulates RET endocytosis, and heparan sulfate participates in assembly of the signaling complex. In the peripheral nervous system NRTN acts as a target-derived retrograde trophic factor—retrogradely transported in a GFRα coreceptor-specific manner—that is essential for postnatal survival and target innervation by parasympathetic (cranial, cardiac, lacrimal, penile), sensory, and enteric neurons, and for retinal function via horizontal and amacrine cells. Beyond neurons, muscle-secreted NRTN functions as a myokine that retrogradely promotes slow motor neuron identity while increasing muscle oxidative metabolism; in the immune compartment NRTN (downstream of IFN-induced RET/GFRα2 up-regulation) dampens viral pro-inflammatory responses in lung macrophages; and in bone, sympathetic cholinergic fibers maintain osteocyte survival via NRTN/GFRα2 signaling. NRTN production in the striatum is controlled by Hedgehog signaling in primary cilia of cholinergic and parvalbumin interneurons and astrocytes, linking pathogenic LRRK2 and GBA1 mutations to reduced NRTN output and dopaminergic neuron vulnerability in Parkinson's disease.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NRTN is a secreted GDNF-family neurotrophic factor that signals by binding the GPI-anchored co-receptor GFRα2, which then recruits and dimerizes the RET receptor tyrosine kinase to trigger downstream signaling [#0, #1, #6]. Structural studies define the assembly: NRTN and GFRα2 impose a specific RET dimerization mode that juxtaposes two kinase domains for cross-phosphorylation, with the RET cysteine-rich domain contacting NRTN and the RET calcium-binding site contacting GFRα2 domain 3; the resulting dimeric complex further packs into a tetramer that regulates RET endocytosis, and a heparan sulfate-binding site on NRTN participates in complex assembly and modulates in vivo exposure [#0, #1, #2]. Downstream of RET, NRTN activates PI3K and MAPK and, in an isoform-specific manner (GFRα2c/RET9), drives serine-727 phosphorylation of mitochondrially localized STAT3 to support neurite outgrowth through a transcription-independent route [#5, #25]. Physiologically, NRTN functions as a target-derived retrograde trophic factor transported in a GFRα coreceptor-specific manner and required for postnatal survival and target innervation of parasympathetic neurons—including lacrimal, cardiac, and penile populations—as well as sensory neurons and retinal horizontal/amacrine cells [#3, #7, #8, #9, #10, #11]. Beyond classical neurotrophism, NRTN acts as a muscle-secreted myokine that retrogradely promotes slow motor neuron identity while raising muscle oxidative metabolism [#12], supports a sympathetic-cholinergic neuro-osteocyte survival interface in bone [#14], and dampens pro-inflammatory cytokine release from interferon-primed lung macrophages [#22]. Its striatal production is controlled by Hedgehog signaling in primary cilia, linking pathogenic LRRK2 mutations to reduced NRTN output and dopaminergic vulnerability [#27]. NRTN/GFRα2/RET signaling is also co-opted by pancreatic, colorectal, hepatocellular, and acute myeloid leukemia cells to drive proliferation, invasion, and survival [#15, #23, #24, #31].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established that NRTN is a target-derived factor delivered by retrograde axonal transport and that its uptake is coreceptor-specific rather than shared with GDNF, defining how peripheral neurons distinguish GDNF-family ligands.\",\n      \"evidence\": \"In vivo sciatic nerve retrograde transport with cross-competition in dorsal root ganglion neuron populations\",\n      \"pmids\": [\"10531437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the molecular transport machinery\", \"Receptor isoform usage not dissected at structural level\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Genetic loss of GFRα2 separated NRTN's role from GDNF's: NRTN/GFRα2/RET is dispensable for early gangliogenesis but essential for postnatal parasympathetic survival and target innervation.\",\n      \"evidence\": \"GFRα1, GFRα2, and RET knockout mouse histology and innervation analysis; penile retrograde transport plus GFRα2-knockout phenotyping\",\n      \"pmids\": [\"11069590\", \"10770848\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling events not assayed\", \"Mechanism of selective postnatal dependence unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined a concrete physiological output of NRTN signaling—parasympathetic innervation of the lacrimal gland and ocular surface homeostasis—through systematic knockout phenotyping.\",\n      \"evidence\": \"NRTN knockout mouse tear function, ocular surface inflammation, and innervation readouts\",\n      \"pmids\": [\"14507865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-autonomous vs systemic effects not separated\", \"Signaling pathway within neurons not addressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed NRTN promotes ciliary neuron survival exclusively through GFRα2 and, unlike GDNF, independently of TGFβ, distinguishing the two ligands' receptor-recruitment requirements.\",\n      \"evidence\": \"Receptor-specific neutralizing antibodies, radioligand binding, and neuronal survival assays in ciliary ganglion neurons\",\n      \"pmids\": [\"17953664\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding\", \"Molecular basis of GFRα2 membrane recruitment not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified the specific retinal and intracellular signaling targets of NRTN—horizontal/amacrine cells via PI3K and MAPK rather than photoreceptors—clarifying which cell types carry the receptor complex.\",\n      \"evidence\": \"NRTN/RET knockout and conditional mice with electroretinography; chick retinosphere PI3K/MAPK pathway analysis\",\n      \"pmids\": [\"18417692\", \"18673446\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Connection between pathway activation and specific functional output incomplete\", \"Retinosphere is an in vitro model\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Quantified NRTN's requirement for presynaptic cardiac cholinergic innervation and vagal control of heart rate, localizing its action to neuron maintenance rather than postsynaptic responsiveness.\",\n      \"evidence\": \"Nrtn knockout cardiac neuron counts, ACh measurement, vagal stimulation, and isolated atria pharmacology\",\n      \"pmids\": [\"19176599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trophic mechanism vs developmental specification not separated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Resolved an isoform-specific, transcription-independent signaling route: NRTN drives serine-727 STAT3 phosphorylation localized to mitochondria to support neurite outgrowth.\",\n      \"evidence\": \"Isoform-specific expression, dominant-negative STAT3 mutants, subcellular fractionation, and neurite outgrowth assays\",\n      \"pmids\": [\"23872421\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding\", \"Mechanism by which mitochondrial P-Ser-STAT3 promotes outgrowth unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Provided the first three-domain GFRα2 structure with NRTN and identified a heparan sulfate-binding site that modulates functional affinity through avidity and controls in vivo exposure.\",\n      \"evidence\": \"X-ray crystallography of NRTN and NRTN/GFRα2, mutagenesis, biophysical binding, and in vivo pharmacokinetics\",\n      \"pmids\": [\"29414779\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RET engagement not captured in this structure\", \"Role of heparan sulfate in cellular signaling output not directly tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Determined the architecture of the complete NRTN/GFRα2/RET extracellular complex, revealing the specific contacts and RET dimerization mode that enable kinase cross-phosphorylation, plus a tetramer that regulates RET endocytosis.\",\n      \"evidence\": \"Two independent cryo-EM structures of the reconstituted ternary complex with cell-based endocytosis assays\",\n      \"pmids\": [\"31535977\", \"31392261\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of tetramer formation in cells not fully resolved\", \"Link between endocytosis and signaling duration not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Expanded NRTN beyond classical neurotrophism by establishing it as a muscle-secreted myokine that retrogradely specifies slow motor neuron identity while reprogramming muscle toward oxidative metabolism.\",\n      \"evidence\": \"Muscle-specific HSA-NRTN transgenic mice with RNA-seq of motor neuron somas and metabolic phenotyping; differential enteric neuron regulation by calcium imaging\",\n      \"pmids\": [\"34592133\", \"33444816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor-level signaling mediating motor neuron specification not detailed\", \"Whether endogenous NRTN performs this role at physiological levels untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified non-neuronal trophic and immunomodulatory roles—an NRTN-dependent sympathetic-cholinergic/osteocyte survival interface in bone and dampening of macrophage inflammation downstream of interferon-induced receptor upregulation.\",\n      \"evidence\": \"Conditional/global knockout mice with micro-CT and exercise models in bone; human lung macrophage cultures with IFN stimulation and cytokine measurement\",\n      \"pmids\": [\"35276096\", \"33020210\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab findings\", \"Direct NRTN signaling readouts in macrophages and osteocytes limited\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated that NRTN signaling is hijacked across multiple cancers to drive proliferation, invasion, EMT, angiogenesis, and survival via GFRα2/RET and PI3K/AKT/mTOR.\",\n      \"evidence\": \"Knockdown/overexpression functional assays, xenograft/metastasis models, RET inhibition, and Co-IP across pancreatic, colorectal, hepatocellular, and AML systems\",\n      \"pmids\": [\"24067900\", \"31392261\", \"29654265\", \"35114191\", \"37211171\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab studies per tumor type\", \"NRTN's specific contribution vs paracrine RET activation not always separated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Placed NRTN production downstream of Hedgehog/primary cilia signaling in striatal interneurons and astrocytes, connecting pathogenic LRRK2 to reduced NRTN and dopaminergic vulnerability, and identified BHLHE40 as a direct transcriptional repressor of NRTN in macrophages.\",\n      \"evidence\": \"LRRK2 mutant mice with MLi-2 treatment, cilia immunofluorescence, and Nrtn expression; ChIP-qPCR and luciferase promoter assays with in vivo asthma epistasis\",\n      \"pmids\": [\"40591712\", \"40467844\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from reduced NRTN to dopaminergic loss not directly tested by rescue\", \"Single-lab transcriptional findings\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NRTN's distinct cellular outcomes (survival, axon outgrowth, metabolic reprogramming, immunosuppression, oncogenic growth) are selected from a shared GFRα2/RET signaling core remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking signaling complex stoichiometry to context-specific output\", \"Endogenous-level contributions in non-neuronal tissues largely inferred from gain-of-function\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 1, 2, 6]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 12, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 5, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 11, 19]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 9, 17]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [22, 30]}\n    ],\n    \"complexes\": [\"NRTN/GFRα2/RET ternary signaling complex\"],\n    \"partners\": [\"GFRA2\", \"RET\", \"GFRA1\", \"TANGO1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}